EAGLE GLOBAL ADVISORS LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 307 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
EAGLE GLOBAL ADVISORS LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$2,865,000
-2.0%
156,897
-2.3%
0.21%
-7.8%
Q4 2020$2,923,000
-4.3%
160,586
-6.2%
0.23%
-16.4%
Q3 2020$3,054,000
-1.4%
171,202
-0.9%
0.28%
-1.8%
Q2 2020$3,097,000
+13.7%
172,715
-3.8%
0.28%
+1.4%
Q1 2020$2,724,000
-26.4%
179,464
-4.3%
0.28%
+47.6%
Q4 2019$3,701,000
+75.7%
187,565
+53.2%
0.19%
+107.8%
Q3 2019$2,106,000
-12.9%
122,440
-10.3%
0.09%
-7.2%
Q2 2019$2,417,000
+13.4%
136,544
+30.4%
0.10%
+16.9%
Q1 2019$2,132,000104,6720.08%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders